BIGHIANI, FEDERICO
 Distribuzione geografica
Continente #
AS - Asia 143
NA - Nord America 143
EU - Europa 137
SA - Sud America 25
AF - Africa 1
Totale 449
Nazione #
US - Stati Uniti d'America 136
SG - Singapore 54
CN - Cina 38
RU - Federazione Russa 33
IT - Italia 25
DE - Germania 23
HK - Hong Kong 23
BR - Brasile 21
GB - Regno Unito 15
VN - Vietnam 13
FI - Finlandia 12
AT - Austria 6
IE - Irlanda 6
CA - Canada 4
FR - Francia 4
IN - India 4
NL - Olanda 4
BD - Bangladesh 3
MX - Messico 3
BH - Bahrain 2
CO - Colombia 2
CZ - Repubblica Ceca 2
PL - Polonia 2
AL - Albania 1
AR - Argentina 1
DZ - Algeria 1
EC - Ecuador 1
GR - Grecia 1
IQ - Iraq 1
JP - Giappone 1
LV - Lettonia 1
OM - Oman 1
PT - Portogallo 1
SA - Arabia Saudita 1
SE - Svezia 1
TH - Thailandia 1
TR - Turchia 1
Totale 449
Città #
Singapore 24
Hong Kong 23
Dallas 22
Ashburn 19
Beijing 18
Los Angeles 16
Munich 15
Turku 9
Milan 8
Rome 8
Dublin 6
Moscow 6
Brooklyn 5
Ho Chi Minh City 5
Boston 4
Falkenstein 4
Orem 4
Redondo Beach 4
Boardman 3
Cremona 3
Helsinki 3
Manchester 3
Montreal 3
New York 3
Poplar 3
Vienna 3
Amsterdam 2
Buffalo 2
Cormano 2
Cuiabá 2
Denver 2
Dongguan 2
Düsseldorf 2
Manama 2
Mexico City 2
Olomouc 2
Portsmouth 2
Santa Clara 2
Shanghai 2
Warsaw 2
Ankara 1
Athens 1
Atlanta 1
Bangkok 1
Barranquilla 1
Belo Horizonte 1
Bologna 1
Brasília 1
Campinas 1
Canoas 1
Caraguatatuba 1
Caruaru 1
Chandigarh 1
Changsha 1
Charleston 1
Chennai 1
Chicago 1
City of London 1
Dhaka 1
Djelfa 1
Duque de Caxias 1
Erbil 1
Fountain Valley 1
Germantown 1
Goiânia 1
Grand Rapids 1
Guayaquil 1
Ha Long 1
Hanoi 1
Hefei 1
Hyderabad 1
Hải Dương 1
Iaciara 1
Itapecerica 1
Jequié 1
Lauro de Freitas 1
Lauterbourg 1
London 1
Manhuaçu 1
Medina 1
Miami 1
Mogi Guaçu 1
Montes Claros 1
Mumbai 1
Muscat 1
Nam Định 1
Necochea 1
Ninh Bình 1
Pasto 1
Phoenix 1
Ramenskoye 1
Riga 1
Rio Brilhante 1
Rock Hill 1
Saronno 1
Serra 1
Shenzhen 1
Stockholm 1
São José do Rio Preto 1
São Paulo 1
Totale 312
Nome #
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial 81
Differences in Trunk Acceleration-Derived Gait Indexes in Stroke Subjects with and without Stroke-Induced Immunosuppression 63
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 59
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 47
Multiscale Entropy Algorithms to Analyze Complexity and Variability of Trunk Accelerations Time Series in Subjects with Parkinson’s Disease 45
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting 43
High-frequency episodic migraine: Time for its recognition as a migraine subtype? 38
Expression of miR-155 in monocytes of people with migraine: association with phenotype, disease severity and inflammatory profile 37
Oculo-vestibular signs in experimentally induced migraine attacks: an exploratory analysis 32
Clinical and instrumental gait phenotyping in people with GLUT-1 deficiency syndrome 12
null 11
Totale 468
Categoria #
all - tutte 2.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.090


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202310 0 0 0 0 1 0 0 1 7 1 0 0
2023/202414 2 1 1 0 2 0 0 0 0 1 1 6
2024/2025211 3 2 5 2 6 39 26 8 44 11 30 35
2025/2026233 44 27 29 43 70 20 0 0 0 0 0 0
Totale 468